Tuesday, April 23, 2013
MetroWest Place, the iconic five-story glass top office building in Framingham, sold last week to a New Jersey firm.
A five-story office building, formerly occupied by Genzyme Corp., was sold to a New Jersey firm. The broker told the Worcester Business Journal that the company is planning a major expansion and plans to renovate the building, known as MetroWest Place. The iconic glass top building was sold to Normandy Real Estate Partners for $5.5 million, according to the broker, Richards Barry Joyce & Partners. The seller was Crosspoint Associates of Natick. The property is located near 9/90 Corporate Center and The Framingham Technology Park. Genzyme had occupied the 95,000 square-foot office building until 2012.
Friday, March 1, 2013
On Feb. 28, more than 180 Genzyme employees made their second annual trek across a
nearly 30-mile course to raise awareness and show their support for International Rare
Thursday, more than 180 Genzyme employees made their second annual trek across a nearly 30-mile course to raise awareness and show their support for International Rare Disease Day, which is celebrated annually on Feb. 28. The course spanned four Genzyme facilities in Massachusetts, as runners made their way from Framingham, to Waltham, to Allston and crossed the finish line in Cambridge. Events were held at each of Genzyme's four sites in the Commonwealth, as fellow colleagues rallied the arriving and departing runners and raised funds for the National Organization for Rare Disorders. Emma Rooney, a Gaucher patient from the National Gaucher Foundation of Canada, and Stefanie Putkowski, a representative from National Organization for Rare …
Saturday, February 2, 2013
Warren made her first public comments about Scott Brown's decision not to run for Senate in the upcoming special election.
Elizabeth Warren, Massachusetts' newest and now senior senator, toured Genzyme in Framingham on Friday and met with the company's CEO, David Meeker. After the tour, Warren commented on the importance of investing in Massachusetts' infrastructure to ensure companies like Genzyme are able to succeed. Genzyme opened a new $330 million facility in 2012 in Framingham. "This [company] is here in Framingham because of all the investments we in Massachusetts make," Warren said. "Those are the investments we make to make this happen." Meeker commented on the importance of Warren coming to the Genzyme facility. "I'm really glad Elizabeth is here, Meeker said. "It is important to bring attention to Framingham and MetroWest and the jobs we create…
Wednesday, October 24, 2012
The gala event Thursday aims to raise $160,000 to benefit more than 3,500 youth in Framingham, Marlborough and Hudson; tickets still available.
The Boys & Girls Clubs of MetroWest will honor its 2012 Partners for Youth a tomorrow night, Oct. 25 at its Bids for Kids Auction & Gala held at the Sheraton Framingham Hotel. The event is also feature a silent auction, Fund-A-Need and a inspirational youth speaker. Susan Wornick, anchor of WCVB- TV’s Channel 5 News will be joining us again this year as our celebrity emcee for the event. The Boys & Girls Clubs of MetroWest aims to raise $160,000 to benefit their quality out-of-school programming provided to over 3,500 youth each year in Marlborough, Framingham and Hudson. A special thanks to the gala sponsors who recognize the important mission of the Boys & Girls Clubs of Metrowest and have invested in an organization that helps so many …
Tuesday, October 23, 2012
Genzyme held a grand opening for its new biomedical manufacturing facility in Framingham Monday, which employees 500, and bring the total number of Genzyme employees in town to 2,300.
Genzyme held a grand opening for its new biomedical manufacturing facility in Framingham Monday, which will employee 500. With the additional of the new 57,000 square foot 68 New York Ave. building, Genzyme now employees 2,300 in Framingham alone. Genzyme, a Sanofi subsidiary, is the third-largest biotechnology company in the world. The newest plant's sole purpose is to produce a drug called Fabrazyme, which treats people world-wide inflicted with a genetic disease. The cost of the drug annually for one patient is $200,000. It takes about 8 months to produce the drug, which begins with a single cell from a Chinese hamster's ovaries. Gov. Deval Patrick, Congressman Ed Markey, state, local and community leaders attended Monday morning's …
Monday, October 1, 2012
The janitors who keep New England’s cities sparkling earn too little to make ends meet. That’s wrong, said the Union Local 615 President.
Monday, October 1, 2012
UPDATED at 11:15 a.m. At 2 a.m. this morning, the union announced a tentative agreement had been reached on a new contract. The agreement prevented a possible strike. In an e-mailed statement, Union spokeswoman Renee Asher called the deal “good for workers, good for the industry and good for New England.” the Union plans to announce information about the tentative agreement this afternoon. *** The union contract for 14,000 janitors in Massachusetts, New Hampshire and Rhode Island expired at midnight Sunday, and with negotiations for a new contract still unsettled, the janitors could strike as soon as Monday, reported Boston.com Since late August, the Local 615 of the Service Employees International Union and the Maintenance Contractors of…
Thursday, August 30, 2012
The Metropolitan Area Planning Council outlined a series of strategies to ease traffic crunches around Framingham's western industrial parks, where 9,000 people commute to, and 84 percent commute solo.
Framingham is moving down the road to ease traffic congestion and improve access to the Framingham Tech Park and the 9/90 Corporate Center on the Western border of town. The Metropolitan Area Planning Council presented its study of the industrial/corporate areas to the Framingham Board of Selectmen Tuesday evening. The study is funded by federal grants. Council representatives emphasized that the presentation was a first step in addressing the expected growth of workers commuting to the area. The Council's overall objectives are more economic development, reduced employee driving to and from the sites and improved employment opportunities. “We need to make the point that we would do nothing to discourage future development of the Tech Park…
Friday, January 20, 2012
Genzyme has not announced plans for the property's use; but owns two abutting parcels.
Genzyme Corporation purchased 10 California Ave. from Columbia Electric Corp. for $8.1 million, reported CoStar Group, headquartered in Washington, D.C. The one-story, 62,666-square-foot, building was built in 1968. The property is on a 4.7-acre parcel in the Framingham Industrial Park. The building has a 21-foot clear height, seven loading docks and one drive-in bay. Genzyme owns two abutting parcels to the property and has not set plans for its intended use. Framingham assessed the 10 California Ave. property at $3.534 million last year and $3.380 million this year.
Thursday, January 19, 2012
The plant will manufacture Fabrazyme, an enzyme replacement therapy to treat a genetic disorder.
Genzyme, now owned by France-based Sanofi, announced Wednesday, Jan. 18 the European Medicines Agency (EMA) has approved its manufacturing plant in Framingham, for the production of Fabrazyme®. “This approval by the EMA represents an important milestone in our manufacturing recovery and path toward unconstrained supply for all patients,” said Genzyme’s President and CEO David Meeker in a statement release by the company. “Providing the Fabry community with consistent access to treatment, increasing our inventory of Fabrazyme® and working toward all regulatory approvals of our Framingham plant are our highest priorities, and we remain on track to achieve all of these crucial goals.” The complete return to normal supply levels of Fabrazyme® …
Wednesday, January 11, 2012
A Genzyme employee was struck by a van at 68 New York Ave. while in the crosswalk, according to witnesses.
Joseph Mallory, 30, a Genzyme employee was struck on New York Ave. around 8:30 a.m. Wednesday New York Avenue was closed for a couple of hours by Framingham Police. Framingham Fire Department requested a Medflight helicopter. Scanner reports had it anding on Route 9 to taken the pedestrian to a Boston hospital. Scanner reports identified the pedestrian as a man, in his 30s, with femur injury and difficulty breathing. Traffic was a mess in that area all morning, as Framingham Police and the Massachusetts State Police reconstruction team were investigating. Witness reports had the pedestrian struck by a van, while he was in the crosswalk. The driver of the van was identified as Andre Desouza of Marlborough. Framingham Police are on the scene…